Innate Pharma (IPHA) Long-Term Deferred Tax (2018 - 2024)
Innate Pharma's Long-Term Deferred Tax was $9.82 million in the quarter ended Jun 30, 2024, down 6.7% from $10.53 million a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Long-Term Deferred Tax (2018 - 2024) Analysis & Trends
As of Dec 31, 2023, Long-Term Deferred Tax at Innate Pharma came in at $9.74 million, up 7.9% from the prior year.
- Long-Term Deferred Tax shows a five-year compound annual growth rate of 40.5% (years ended Dec 2018 to Dec 2023).
- In earlier years, Long-Term Deferred Tax was $9.03 million in the year ended Dec 31, 2022 (+57.0%), $5.75 million in the year ended Dec 31, 2021 (-28.9%), $8.09 million in the year ended Dec 31, 2020 (+529.2%) and $1.29 million in the year ended Dec 31, 2019 (-27.8%).
- Quarterly Long-Term Deferred Tax has moved between $1.27 million (the quarter ended Jun 30, 2020) and $10.53 million (the quarter ended Jun 30, 2023) over five years.
- Compared with a year earlier, Long-Term Deferred Tax was higher in three of the last four quarters, with growth averaging 20.8%.
- The best year-over-year quarter for Long-Term Deferred Tax over five years was the quarter ended Dec 31, 2020 (growth of 493.6%); the worst was the quarter ended Dec 31, 2021 (a decline of 31.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Innate Pharma | 142.45 Mn | -64.74 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 9.77 Mn |
| Dec 31, 2023 | 9.97 Mn |
| Jun 30, 2023 | 10.51 Mn |
| Dec 31, 2022 | 9.13 Mn |
| Jun 30, 2022 | 8.13 Mn |
| Dec 31, 2021 | 5.69 Mn |
| Jun 30, 2021 | 6.43 Mn |
| Dec 31, 2020 | 8.72 Mn |
| Jun 30, 2020 | 1.43 Mn |
| Dec 31, 2019 | 1.44 Mn |
| Dec 31, 2018 | 1.79 Mn |
API Access
Innate Pharma Long-Term Deferred Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-deferred-tax", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();